1. Ahman, D.L., Eagan, R.T., Bisel, H.F., Hahn, R.G., O’Connell, M.J., Edmondson, J.H.: Evaluation of combination therapy with adriamycin (NSC-123 127) and methotrexate (NSC-740) in patients with disseminated breast cancer. Cancer Chemother. Rep. 6/3, 335–338 (1975a)
2. Ahman, D.L., Bisel, H.F., Hahn, R.G. et al.: An analysis of a multiple-drug program in the treatment of patients with advanced breast cancer utilizing 5-Fluorouracil, cyclophosphamide, and prednisone with or without vincristine. Cancer 36, 1925–1935 (1975b)
3. Ahman, D.L., O’Connell, M.J., Hahn, R.G. Bisel, H.F., Lee, R.A., Edmondson, J.H.: An evaluation of early or delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer undergoing oophorectomy. N. Engl. J. Med. 29, 356–360 (1977)
4. Band, P.R., Tormey, D.C., Bauer, M.: Induction chemotherapy and maintenance chemo-hormontherapy in metastatic breast cancer (abstr.). Proc. Am. Assoc. Cancer Res. 18, 228 (1977)
5. Baulieu, E.E.: Steroid receptors and hormone receptivity: new approaches in pharmacology and therapeutics. In: Breast cancer, trends in research and treatment. Heuson, J.C., Mattheiem, W.H., Rozencweig, M. (eds.), pp. 165–183. New York: Raven Press 1977